Clinical Trial Update: NeoAdjuvant Theranostic Lutetium Study: The Nautilus Trial [Phase 1, Phase 2]

View source ↗

Summary

This update covers the Nautilus trial, a neoadjuvant lutetium theranostic study for prostate cancer in Phase 1 and Phase 2 that is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING